cross-border M&A Japan
-
Japan’s Medical Device Industry and M&A: A USD 31.5 Billion Market and Global Players Emerging from Kansai
Japan’s medical device sector directly supports human health and life across diagnosis, treatment, monitoring and prevention. The domestic market has reached nearly USD 33 billion, while Kansai, particularly Kobe and Osaka, has developed into a major cluster of internationally active companies, including Sysmex, Nipro and Daiken Medical. Japan also has several hundred independent and semi-independent…
-
Japan’s SIer Industry and M&A: Consolidation Driven by a 77% Succession Gap, Talent Acquisition and Surging DX Demand
Japan’s system integrator, or SIer, sector is now one of the country’s most active areas for M&A. The acceleration reflects three powerful drivers occurring simultaneously: a chronic shortage of IT professionals, rapidly expanding demand for digital transformation, cloud computing and generative AI, and the aging of owner-managers combined with an exceptionally high absence of successors.…
-
Japan’s Pump Industry and M&A: Fragmented Markets and Cross-Border Succession
Japan’s pump industry has long benefited from stable demand as a business-to-business infrastructure sector. Over the past decade, however, its competitive landscape has changed substantially. Transactions including Nikkiso’s acquisition of the Cryogenic Industries group in 2017, its subsequent sale of LEWA and Geveke in 2022, the Dutch Verder group’s acquisition of MicrotracBEL in 2019, Noritz’s…
-
Japan’s Pharmaceutical and Medical Supplies Distribution Sector and M&A: Consolidation Under Drug-Pricing Reform, Generic Supply Disruption and Activist Pressure
Japan’s pharmaceutical and medical supplies distribution sectors form a critical part of the country’s healthcare supply chain, yet they face a combination of structural pressures that are not always visible from outside Japan. According to the Federation of Japan Pharmaceutical Wholesalers Associations’ Pharmaceutical Wholesalers Association Guide 2025, pharmaceutical sales by its member companies totaled USD…
-
Japan’s Cutting Tools Sector and M&A: Structural Transformation Driven by the Race for Tungsten, the EV Transition and Global Consolidation
Introduction: A Less Visible Industry at the Heart of Japanese Manufacturing Cutting tools and cemented-carbide tools perform the final stages of metalworking across automotive components, aircraft, dies and molds, semiconductor manufacturing equipment, construction machinery and medical devices. They support what might be described as the final micron of advanced manufacturing. The product range includes taps,…
-
Japan’s Valve Industry and M&A: Semiconductor, Hydrogen and Data Center Demand Is Redefining Fluid-Control Consolidation
1. Introduction: Why Is Japan’s Valve Industry Entering a New Phase of Consolidation? Valves and other fluid-control equipment are used across nearly every form of industrial and social infrastructure, from water supply systems, building services and petrochemical plants to ships, nuclear power stations, semiconductor manufacturing equipment, hydrogen stations and data center cooling systems. The sector…
-
Japan’s Food Manufacturing Sector and M&A: Mid-Market Consolidation as Corporate Focus and Private Equity Investment Advance in Parallel
Introduction: Quiet Industry Consolidation Within a Mature Market Japan’s food manufacturing sector has long been discussed in terms of a mature domestic market, price competition, rising raw-material and labor costs, and the logistics constraints that became particularly visible in 2024. Yet company results also reflect supportive trends, including demand for affordable everyday products, health-conscious consumption,…
-
Japan’s Insurance Agency Sector and M&A: Regulatory Change, Major-Group Consolidation and Private Equity Roll-Ups
Japan’s insurance agency sector is unusual in that its regulatory environment, ownership structure and distribution channels are all changing at the same time. The market is being reshaped by stronger supervision following misconduct at a major multi-insurer agency, amendments to the Insurance Business Act, consolidation of agency subsidiaries by leading life and non-life insurers, continued…
-
How to Evaluate M&A Advisory Firms for Divestitures in Japan Based on Real Execution Capability
For foreign companies considering divestitures in Japan such as selling subsidiaries or non-core businesses in Japan, selecting a “reliable” M&A advisor is one of the most consequential decisions in the entire process. This is particularly true when navigating the fragmented landscape of M&A advisory firms in Japan, where brand reputation and headline deal announcements do…
-
Bottlenecks in Japan Market Entry and Operations — and M&A as a Strategic Option to Accelerate Capability Build‑Out and Strengthen Competitiveness
Japan remains one of the most important advanced markets in the world—large in absolute demand, demanding in quality and execution, and strategically meaningful for global credibility. Yet for many foreign‑owned companies, the key challenge is not whether Japan is attractive, but whether the Japan business can scale at the speed, consistency, and governance standard expected…